words lines 0 60 0 20 top 50% bottom top 1 0 0 .22 back 1 0 .001 1 .1 1.5 none top bottom center center true 1 none top top center top true 0 200 .001 none
top bottom top center true 1 none top bottom bottom bottom true 1 none


We are proud to be making a profound difference in the lives of people with cancer, by providng oncology treatments on the WHO Essential Medicines List.

Juniper Biologics Healthcare Therapy Oncology Rare Orphan Diseases Gene Therapy Care Onology Man


LEDAGA® (chlormethine) gel is an alkylating drug indicated for the topical treatment of MF-CTCL in adult patients. LEDAGA® is a gel which is applied topically once a day. The drug has been approved by the European Commission (for the treatment of MF-CTCL in adult patients). Since June 2019, LEDAGA® is commercialized in more than 30 countries including Europe, Canada, Latin America.*

*The exact therapeutic indication and registration status may be different in each country. Please consult the official approved product information in your country.